Feature | January 22, 2014

ProTom Proton Therapy Technology Tested in Michigan

ProTom International, Inc. Radiance 330 Proton Therapy Radiation Therapy

Physicist measures Radiance 330 proton beam characteristics

ProTom International, Inc. Radiance 330 Proton Therapy Radiation Therapy

Radiance 330 Proton System 250 MeV proton beam spot profile radial symmetry

ProTom International, Inc. Radiance 330 Proton Therapy Radiation Therapy

Radiance 330 Proton System Treatment Room at the McLaren Proton Therapy Center

January 22, 2014 — Physicists at the McLaren Proton Therapy Center (MPTC) in Flint, Michigan conducted clinical testing of ProTom International, Inc.’s Radiance 330 Proton Therapy System.
 
Radiance 330 employs the Proton Beam Scanning (PBS) treatment delivery technique, and the McLaren team tested key characteristics of the scanned beam delivered to instrumentation in water phantoms
 
“We have been impressed by the stability of the system during our testing,” said Sung Park, Ph.D., chief physicist at MPTC. “The spot size and spot profiles are well-described by a Gaussian distribution and demonstrate excellent radial symmetry. This bodes well for the dosimetry we can expect from ProTom's system.”
 
The U.S. Food and Drug Administration (FDA) has not yet cleared Radiance 330 Proton Therapy System for commercial distribution in the United States.
 

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.